Cancer Driving Mutations in Endometriosis Lesions and Development of Progesterone Resistance | MicrobiomeTrials← Back to trialsNCT03756480
Cancer Driving Mutations in Endometriosis Lesions and Development of Progesterone Resistance
RecruitingOBSERVATIONAL
Trial Details
Start: 2020-10-01Est. Completion: 2024-10-01
Enrollment target: 135 participants Locations- Yale School of Medicine, New Haven, Connecticut, United States
- Johns Hopkins Hospital, Baltimore, Maryland, United States
- Vanderbilt University Medical Center, Nashville, Tennessee, United States
Other microbiome trials you might be interested in
Ovarian EndometriomaEndometriosis
Background: Ovarian endometrioma is the most common manifestation of endometriosis and is associated with chronic pelvic…
Multiple LocationsEst. completion Dec 30, 2026
Endometriosis
This study aims to test if making changes to diet can affect the pelvic pain associated with endometriosis. One group wi…
Hamilton, CanadaCompleted Jun 2026